Why Use KILR Effector Cells for QC & Lot Release?
26th November 2018
Category: Bioanalytical
By: Laura McAleer, PhD - Senior Scientist, Product Development,
Therapeutic monoclonal antibodies are able to bind to their target antigen and can also bind to Fc receptors found on the surface of effector immune cells. This results in target cell death by Antibody-Dependent Cell-mediated Cytotoxicity (ADCC). Traditional ADCC assays can be complex and require the use of freshly isolated primary human cells such as More
Scientist’s Review of BEBPA 2018
2nd November 2018
Category: Bioanalytical
By: Ben Tyrrell, PhD - Scientist, Product Development, Laura McAleer, PhD - Senior Scientist, Product Development,
At the end of September 2018 Sartorius Stedim BioOutsource attended the 11th Annual EUR BEBPA Bioassay conference in Budapest, Hungry. The conference ran over three days with the first day containing workshops and day 2-3 having talks and poster presentations. The aim of this conference was to provide discussions on topics of current interest to the More